Jie Wang, Rui Wan, Shan Zeng, Lin Wu, Hua Zhong, Jingxun Wu, Guowu Wu, Jianchun Duan, Shuqing Wei, Zhiye Zhang, Linlin Wang, Juan Li, Jingfeng Liu, Yu Chen, Xinjing Wang, Xiaoli Hou, Qingyu Wang, Haoyu Yu, Jing Li. "A phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX43 (anti-PD-L1 ADC) in patients with advanced/metastatic solid tumors.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3025